Promising Research
The following studies are underway in the late stages of research. We're watching them closely.
MS
April 11, 2022
BTK Inhibitors and Novel Approaches to Multiple Sclerosis
https://www.neurologylive.com/view/btk-inhibitors-and-novel-approaches-to-multiple-sclerosis
October 20, 2020
Anti-inflammatory therapy shows promise in slowing progression of multiple sclerosis
https://www.sciencedaily.com/releases/2020/10/201020131338.htm
December 20, 2020
Researchers have identified an immune cell in mice that promotes axon regeneration and neuronal survival and could potentially be harnessed as a treatment for brain, spinal cord, and optic nerve damage.
January 19, 2021
Fatty acid may help combat multiple sclerosis
https://news.yale.edu/2021/01/19/fatty-acid-may-help-combat-multiple-sclerosis
Regrowing Myelin
Fractalkine: a breakthrough for multiple sclerosis treatment?
https://www.regmednet.com/fractalkine-a-breakthrough-for-multiple-sclerosis-treatment/
Simple sugar possible therapy for repairing myelin in multiple sclerosis
https://www.sciencedaily.com/releases/2020/10/201007145416.htm
Mechanisms identified to restore myelin sheaths after injury or in multiple sclerosis
https://www.sciencedaily.com/releases/2020/08/200824105529.htm
Pain
Advances with Long Non-Coding RNAs in Diabetic Peripheral Neuropathy (A peer-reviewed study)
Kolon begins testing gene therapy for neuropathic pain in US
http://www.koreabiomed.com/news/articleView.html?idxno=8095
EicOsis EC5026 Granted Fast Track Designation by FDA for Neuropathic Pain
EC5026 just passed Phase 1a Clinical Trial, Nov 15, 2020: